BACKGROUND: We assessed the utility of the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) as single agent therapy and in combination with conventional chemotherapy for thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS: Eight cell lines from four types of thyroid cancer (papillary. follicular. anaplastic. https://www.diegojavierfares.com/flash-offer-Finney-Two-Handle-High-Arc-Bathroom-Faucet-p8561-super-offer/